-
221
Physical Exercise as a Diagnostic, Rehabilitation, and Preventive Tool: Influence on Neuroplasticity and Motor Recovery after Stroke
Published 2015-01-01“…Stroke remains a leading cause of adult motor disabilities in the world and accounts for the greatest number of hospitalizations for neurological disease. Stroke treatments/therapies need to promote neuroplasticity to improve motor function. …”
Get full text
Article -
222
Bioactive compounds from Chinese herbal plants for neurological health: mechanisms, pathways, and functional food applications
Published 2025-01-01“…Traditional Chinese Medicine (TCM), with its holistic approach and multi-target effects, has gained increasing attention in the treatment of neurological diseases. This review explores bioactive compounds derived from Chinese herbal plants, focusing on their mechanisms of action, underlying pathways, and potential applications in functional food development. …”
Get full text
Article -
223
Fever, Myositis, and Paralysis: Is This Inflammatory Myopathy or Neuroinvasive Disease?
Published 2016-01-01“…He was treated supportively and his muscle and neurologic disease gradually improved. At 12-month follow-up his muscle enzymes had normalized and his weakness had improved to 5/5 strength in bilateral legs and 3/5 strength in the right arm.…”
Get full text
Article -
224
Optic Chiasmitis as an Isolated Manifestation of Myelin Oligodendrocyte Glycoprotein-Associated Disease – a Case Report
Published 2024-10-01“…We hope that this ophthalmic manifestation of a rare neurological disease will make other clinicians aware of the utter importance of careful evaluation of visual disturbances.…”
Get full text
Article -
225
Ketogenic Diet: A Review of Composition Diversity, Mechanism of Action and Clinical Application
Published 2024-01-01“…The beneficial effects of the KD on neurological diseases are related to the reconstruction of myelin sheaths of neurons, reduction of neuron inflammation, decreased production of reactive oxygen species, support of dopamine production, repair of damaged mitochondria and formation of new ones. …”
Get full text
Article -
226
Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
Published 2014-01-01Get full text
Article -
227
Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases
Published 2023-01-01“…This agent has shown its efficacy in preventing and treating neurological diseases such as migraine, Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, amyotrophic lateral sclerosis, and Friedreich’s ataxia. …”
Get full text
Article -
228
Electroacupuncture Improved Hippocampal Neurogenesis following Traumatic Brain Injury in Mice through Inhibition of TLR4 Signaling Pathway
Published 2017-01-01“…The protective role of electroacupuncture (EA) treatment in diverse neurological diseases such as ischemic stroke is well acknowledged. …”
Get full text
Article -
229
Matrix Metalloproteinases in patients with Multiple Sclerosis.
Published 2007-05-01“…<strong>Methods:</strong> the cerebrospinal fluid (CSF) samples taken from 31 patients suffering from multiple sclerosis and a control group formed by 21 patients without neurological disease. The metalloproteinase 2 and 9 activities in the cerebrospinal fluid were determined by zimográfica technique through polyacrylamide gel electrophoresis. …”
Get full text
Article -
230
Influence of Partnership Relationships on Long-Term Neurological Rehabilitation in Germany: Protocol for a Qualitative Retrospective Study
Published 2025-01-01“… BackgroundAcquired neurological diseases entail significant changes and influence the relationship between a patient and their significant other. …”
Get full text
Article -
231
Preclinical use of a clinically-relevant scAAV9/SUMF1 vector for the treatment of multiple sulfatase deficiency
Published 2025-01-01“…Abstract Background Multiple Sulfatase Deficiency (MSD) is a rare inherited lysosomal storage disorder characterized by loss of function mutations in the SUMF1 gene that manifests as a severe pediatric neurological disease. There are no available targeted therapies for MSD. …”
Get full text
Article -
232
Identifying unstable CNG repeat loci in the human genome: a heuristic approach and implications for neurological disorders
Published 2024-06-01“…Recent studies have implicated GLS, RAI1, GIPC1, MED15, EP400, MEF2A, and CNKSR2 in neurological diseases, with GLS, GIPC1, MED15, RAI1, and MEF2A sharing the same repeat loci reported in this study. …”
Get full text
Article -
233
Immunization‐related complex regional pain syndrome: A systematic review of case reports
Published 2024-12-01“…Outcomes of interest include type of vaccination, patient age, patient sex, time to symptom onset, and medical history including but not limited to previous autoimmune diseases, psychological illness, physical tissue trauma, and neurological disease. Results Initial querying of the five databases yielded 404 articles. …”
Get full text
Article -
234
HIV-Associated Vacuolar Myelopathy and HIV-Associated Dementia as the Initial Manifestation of HIV/AIDS
Published 2019-01-01“…It is a progressive myelopathy that shares features with subacute combined degeneration seen in vitamin B12 deficiency as well as other neurological diseases and can occur synchronously with HIV-associated dementia (HAD). …”
Get full text
Article -
235
Myelopathy as the first manifestation of AIDS
Published 2024-12-01“…Central nervous system diseases in HIV-infected patients can be caused by HIV or opportunistic infections. Neurological diseases associated with HIV have diverse manifestations and may occur in early or late stages. …”
Get full text
Article -
236
Targeting natural antioxidant polyphenols to protect neuroinflammation and neurodegenerative diseases: a comprehensive review
Published 2025-01-01“…Polyphenols, naturally occurring phytonutrients found in plant-based foods, have attracted significant attention for their potential therapeutic effects in neurological diseases and neuroinflammation. These compounds possess diverse neuroprotective capabilities, including antioxidant, anti-inflammatory, and anti-amyloid properties, which contribute to mitigating the progression of neurodegenerative conditions such as Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Dementia, Multiple Sclerosis (MS), Stroke, and Huntington’s Disease (HD). …”
Get full text
Article -
237
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer’s disease biomarkers
Published 2025-01-01“…CSF and plasma p-tau217&231, p-tau181, p-tau217, and p-tau231 and CSF, but not plasma, p-tau181&231 were significantly elevated in all AD continuum groups vs. Neurological Disease Control group. Notably, plasma p-tau217&231 consistently showed an improved diagnostic performance compared with single-site phosphorylation assays – p-tau217 or p-tau231. …”
Get full text
Article -
238
Evaluating neurofilament light chain serum levels as a diagnostic marker for Lyme neuroborreliosis
Published 2025-01-01“…Compared to individuals without neurological disease, LNB patients showed increased serum (median (interquartile range, IQR): 36.3 pg/ml (19.3–112.0) vs 20 pg/ml (12.9–37.3), p < 0.001) and CSF NfL levels (median (IQR): 1000.0 pg/ml (286.0–6471.0) vs 182 pg/ml (99.3–474.0), p < 0.001). …”
Get full text
Article -
239
Exploring the Effectiveness of Machine Learning and Deep Learning Techniques for EEG Signal Classification in Neurological Disorders
Published 2025-01-01“…In conclusion, this research highlights the effectiveness of ML and DL techniques in EEG signal processing, offering valuable contributions to the field of brain-computer interfaces and advancing the potential for more accurate neurological disease classification and diagnosis.…”
Get full text
Article -
240
Spinal ischemia: the rehabilitation potential. А clinical case
Published 2024-12-01“…BACKGROUND: Spinal myeloischemia is a rare but severe neurological disease, associated with high incapacitation level and high social-economical costs due to complications developing during the acute phase. …”
Get full text
Article